Transmembrane-4 Superfamily Proteins CD81 (TAPA-1), CD82, CD63, and CD53 Specifically Associate with Integrin α4β1 (CD49d/CD29)

Journal of Immunology

Volumn 157, Issue 5, 1996, Pages 2039-2047

  Mannion, Brian A ^a   Berditchevski, Fedor ^a   Kraeft, Stine Kathrein ^a   Chen, Lan Bo ^a   Hemler, Martin E ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD53 ANTIGEN; CD81 ANTIGEN; CD82 ANTIGEN; FIBRINOGEN RECEPTOR; HOMING RECEPTOR; INTEGRIN; KAI1 PROTEIN, HUMAN; LEUKOCYTE ANTIGEN; LYSOSOMAL PROTEIN GP53; MEMBRANE PROTEIN; MONOCLONAL ANTIBODY; ONCOPROTEIN; T LYMPHOCYTE ANTIGEN; VERY LATE ACTIVATION ANTIGEN 4;

ARTICLE; CELL ADHESION; CELL LINE; GENETICS; HUMAN; IMMUNOLOGY; ISOLATION AND PURIFICATION; METABOLISM; MOLECULAR WEIGHT; MUTATION;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; CELL ADHESION; CELL LINE; HUMANS; INTEGRIN ALPHA4BETA1; INTEGRINS; KANGAI-1 PROTEIN; MEMBRANE GLYCOPROTEINS; MEMBRANE PROTEINS; MOLECULAR WEIGHT; MUTATION; PLATELET MEMBRANE GLYCOPROTEINS; PROTO-ONCOGENE PROTEINS; RECEPTORS, LYMPHOCYTE HOMING;

EID: 0030239653     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Lobb, R. R., and M. E. Hemler. 1994. The pathophysiologic role of α4 integrins in vivo. J. Clin. Invest. 94:1722.
2. Postigo, A. A., J. Teixidó, and F. Sánchez-Madrid. 1993. The α4β1/VCAM-1 adhesion pathway in physiology and disease. Res. Immunol. 144:723.
3. Hemler, M. E., J. B. Weitzman, R. Pasqualini, S. Kawaguchi, P. D. Kassner, and F. B. Berdichevsky. 1994. Structure, biochemical properties, and biological functions of integrin cytoptasmic domains. In Integrin: The Biological Problem. Y. Takada, eds. CRC Press, Ann Arbor, p. 1.
4. Yamada, K. M., and S. Miyamoto. 1995. Integrin transmembrane signaling and cytoskeletal control. Curr. Opin. Cell Biol. 7:681.
5. Vuori, K., and E. Ruoslahti. 1994. Association of insulin receptor substrate-1 with integrins. Science 266:1576.
6. 3 subunit. J. Cell Biol. 131:807.
7. Rubinstein, E., F. Le Naour, M. Billard, M. Prenant, and C. Boucheix. 1994. CD9 antigen is an accessory subunit of the VLA integrin complexes. Eur. J. Immunol. 24:3005.
8. 1 at cell-cell contact sites. J. Cell Biol. 129:1691.
9. Berditchevski, F., M. M. Zutter, and M. E. Hemler. 1996. Characterization of novel complexes on the cell surface between integrins and proteins with 4 transmembranes (TM4 proteins). Mol. Biol. Cell 7:193.
10. Slupsky, J. R., J. G. Seehafer, S.-C. Tang, A. Masellis-Smith, and A. R. E. Shaw. 1989. Evidence that monoclonal antibodies against CD9 antigen induce specific association between CD9 and the platelet glycoprotein IIb-IIIa complex. J. Biol. Chem. 264:12289.
11. Berditchevski, F., F. Bazzoni, and M. E. Hemler. 1995. Specific association of CD63 with the VLA-3 and VLA-6 integrins. J. Biol. Chem. 270:17784.
12. Horejsí, V., and C. Vlcek. 1991. Novel structurally distinct family of leucocyte surface glycoproteins including CD9, CD37, CD53 and CD63. FEBS Lett. 288:1.
13. Wright, M. D., and M. G. Tomlinson. 1994. The ins and outs of the transmembrane 4 superfamily. Immunol. Today 15:588.
14. Miyake, M., M. Koyama, M. Seno, and S. Ikeyama. 1991. Identification of the motility-related protein (MRP-1), recognized by monoclonal antibody M31-15, which inhibits cell motility. J. Exp. Med. 174:1347.
15. 1 integrin-dependent motility on fibronectin and laminin substrates and enhanced tyrosine phosphorylation. J. Biol. Chem. 270:24092.
16. Anton, E. S., M. Hadjiargyrou, P. H. Patterson, and W. D. Matthew. 1995. CD9 plays a role in Schwann cell migration in vitro. J. Neurosci. 15:584.
17. Ikeyama, S., M. Koyama, M. Yamaoko, R. Sasada, and M. Miyake. 1993. Suppression of cell motility and metastasis by transfection with human motility-related protein (MRP-1/CD9) DNA. J. Exp. Med 177:1231.
18. Masellis-Smith, A., and A. R. E. Shaw. 1994. CD9-regulated adhesion: anti-CD9 monoclonal antibody induce pre-B cell adhesion to bone marrow fibroblasts through de novo recognition of fibronectin. J. Immunol. 152:2768.
19. 1 and fibronectin. J. Exp. Med. 182:1191.
20. Garofalo, A., R. G. S. Chirivi, C. Foglieni, R. Pigott, R. Mortarini, I. Martin-Padura, A. Anichini, A. J. Gearing, F. Sánchez-Madrid, E. Dejana, and R. Giavazzi. 1995. Involvement of the very late antigen 4 integrin on melanoma in interleukin 1-augmented experimental metastasis. Cancer Res. 55:414.
21. 1 on melanoma cells can inhibit the invasive stage of metastasis formation. Cell 77:335.
22. Radford, K. J., J. Mallesch, and P. Hersey. 1995. Suppression of human melanoma cell growth and metastasis by the melanoma-associated antigen CD63 (ME491). Int. J. Cancer 62:631.
23. Dong, J.-T., P. W. Lamb, C. W. Rinker-Schaeffer, J. Vukanovic, T. Ichikawa, J. T. Isaacs, and J. C. Barret. 1995. KAI 1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2. Science 268:884.
24. 1 antibody. J. Cell Biol. 120:537.
25. 1-integrin. J. Exp. Med 178:649.
26. 4 subunit of the integrin VLA-4: distinct effects on adhesion to CS1/ fibronectin, VCAM-1, and invasin. J. Cell Biol. 123:245.
27. 4 subunit cleavage. J. Biol. Chem. 267: 1786.
28. 4/180 formation. Biochem. J. 313:899.
29. Hemler, M. E., C. Huang, Y. Takada, L. Schwarz, J. L. Strominger, and M. L. Clabby. 1987. Characterization of the cell surface heterodimer VLA-4 and related peptides. J. Biol. Chem. 262:11478.
30. Sánchez-Madrid, F., J. A. Nagy, E. Robbins, P. Simon, and T. A. Springer. 1983. A human leucocyte differentiation antigen family with distinct α subunits and a common β subunit: the lymphocyte-function associated antigen (LFA-1), the C3bi complement receptor (OKM1/Mac-1), and the p150,95 molecule. J. Exp. Med 158:1785.
31. Schwartz-Albiez, R., B. Dorken, W. Hofmann, and G. Moldenhauer. 1988. The B cell-associated CD37 antigen (gp40-52): structure and subcellular expression of an extensively glycosylated glycoprotein. J. Immunol. 140:905.
32. Angelisova, P., C. Vlcek, I. Stefanova, M. Lipoldova, and V. Horejsi. 1990. The leukocyte surface antigen CD53 is a protein structurally similar to CD37 and MRC OX-44 antigens. Immunogenetics 32:281.
33. Amiot, M. 1995. CD53 Workshop panel report. In Leukocyte Typing. Vol 5: White Cell Differentiation Antigens. S. F. Schlossman, L. Boumsell, W. Gilks, J. M. Harlan, T. Kishimoto, C. Morimoto, J. Ritz, S. Shaw, R. Silverstein, T. Springer, T. F. Tedder, and R. F. Todd, eds. Oxford University Press, Oxford, p. 556.
34. Fukudome, K., M. Furuse, T. Imai, M. Nishimura, S. Takagi, Y. Hinuma, and O. Yoshie. 1992. Identification of membrane antigen C33 recognized by monoclonal antibodies inhibitory to human T-cell leukemia virus type I (HTLV-1)-induced syncytium formation: altered glycosylation of C33 antigen in HTLV-1-positive T cells. J. Virol. 66:1394.
35. Tedder, T. F., N. Wagner, and P. Engel. 1995. CD81 workshop report. In Leukocyte Typing. Vol 5: White Cell Differentiation Antigens. S. F. Schlossman, L. Boumsell, W. Gilks, J. M. Harlan, T. Kishimoto, C. Morimoto, J. Ritz, S. Shaw, R. Silverstein, T. Springer, T. F. Tedder, and R. F. Todd, eds. Oxford University Press, Oxford, p. 684.
36. Lemke, H., G. J. Hammerling, C. Hohmann, and K. Rajewsky. 1978. Hybrid cell lines secreting monoclonal antibody specific for major histocompatibility antigens of the mouse. Nature 271:249.
37. Oren, R., S. Takahashi, C. Doss, R. Levy, and S. Levy. 1990. TAPA-1, the target of an antiproliferative antibody, defines a new family of transmembrane proteins. Mol. Cell. Biol. 10:4007.
38. 7 on human leukocytes. J. Immunol 153:517.
39. 4 cytoplasmic domain. Mol. Biol. Cell 6:661.
40. Angelisova, P., I. Hilgert, and V. Horejsi. 1994. Association of four antigens of the tetraspan family (CD37, CD53, TAPA-1 and R2/C33) with MHC class II glycoproteins. Immunogenetics 39:249.
41. Imai, T., and O. Yoshie. 1993. C33 antigen and M38 antigen recognized by monoclonal antibodies inhibitory to syncytium formation by human T cell leukemia virus type 1 are both members of the transmembrane 4 superfamily and associate with each other and with CD4 and CD8 in T cells. J. Immunol. 151:6470.
42. Bradbury, L. E., G. S. Kansas, S. Levy, R. L. Evans, and T. F. Tedder. 1992. The CD19/CD21 signal transducing complex of human B lymphocytes includes the target of antiproliferative antibody-1 and Leu-13 molecules. J. Immunol. 149:2841.
43. Schick, M., and S. Levy. 1993. The TAPA-1 molecule is associated on the surface of B cells with HLA-DR molecules. J. Immunol. 151:4090.
44. Detmers, P. A., S. D. Wright, E. Olsen, B. Kimball, and Z. A. Cohn. 1987. Aggregation of complement receptors on human neutrophils in the absence of ligand. J. Cell Biol. 105:1137.
45. Schadendorf, D., J. Heidel, C. Gawlik, L. Suter, and B. M. Czametzki. 1995. Association with clinical outcome of expression of VLA-4 in primary cutaneous malignant melanoma as well as P-selectin and E-selectin on intratumoral vessels. J. Natl. Cancer Inst. 87:366.
46. Utsumi, K., M. Sawada, S. Narumiya, J. Nagamine, T. Sakata, S. Iwagami, Y. Kita, H. Teraoka, H. Hirano, M. Ogata, T. Hamaoka, and H. Fujiwara. 1991. Adhesion of immature thymocytes to thymic stromal cells through fibronectin molecules and its significance for the induction of thymocyte differentiation. Proc. Natl. Acad. Sci. USA 88:5685.
47. Boismenu, R., M. Rhein, W. H. Fischer, and W. L. Havran. 1996. A role for CD81 in early T cell development. Science 271:198.
48. Elices, M. J., L. Osborn, Y. Takada, C. Crouse, S. Luhowskyj, M. E. Hemler, and R. R. Lobb. 1990. VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/fibronectin binding site. Cell 60:577.